FDA Denies Petition To Classify Home Tooth Whiteners As Drugs
This article was originally published in The Rose Sheet
Data in a 2009 petition submitted by the American Dental Association is insufficient to warrant a drug designation for peroxide-containing tooth-whitening products as a group, according to the agency’s April 22 response. Further information on specific product formulations, mechanisms of action and safety profiles would be required for FDA to determine whether they meet the definition of a drug under federal law, the agency says.
You may also be interested in...
Procter & Gamble urges FDA to deny a citizen petition by the American Dental Association to reclassify commercially available tooth whiteners as drugs, saying the petition is motivated by the financial interests of ADA members
The American Dental Association asks FDA to follow through on its promise to evaluate the safety of tooth-bleaching systems and classify the regulatory status of the products, which are rapidly increasing in number
Plaintiffs against the prestige, “clinical” skin-care company are targeting anti-aging claims on its Rose Stem Cell Bio-Repair line and statements about hyaluronic acid’s ultra-moisturizing capabilities, used to market its Water Drench range. PTR faces false advertising class actions in California and New York federal courts, and the former case appears to be headed for trial.